Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term...

Area of Science:

• Immunology
• Vaccinology
• Public Health

Background:

• Hepatitis B virus (HBV) infection in neonates can lead to chronic infection.
• Passive-active immunization strategies aim to prevent perinatal HBV transmission.
• Optimizing neonatal hepatitis B vaccination schedules is crucial for long-term protection.

Purpose of the Study:

• To evaluate factors influencing the protective efficacy and long-term immunogenicity of neonatal passive-active hepatitis B immunization.
• To compare different vaccination schedules, including timing, vaccine types, and immunoglobulin doses.
• To assess the impact of concomitant DKTP vaccination on hepatitis B vaccine effectiveness.

Main Methods:

• Meta-analysis of individual patient data from three randomized controlled trials involving 705 infants.
• Multivariate logistic regression analysis to identify predictive factors for protective efficacy and immunogenicity.
• Long-term follow-up (up to 5 years) to assess sustained seroprotection.

Main Results:

• Overall protective efficacy against HBsAg carriage at 12 months was 92%.
• Maternal HBV DNA level was the sole significant factor influencing protective efficacy (100% efficacy if <150 pg/mL vs. 68% if >150 pg/mL).
• Starting active immunization at 3 months, concomitant with DKTP vaccination, enhanced long-term seroprotection compared to starting at birth.

Conclusions:

• Passive-active hepatitis B immunization is highly effective, primarily dependent on maternal HBV DNA levels.
• The timing of active immunization (birth vs. 3 months) did not significantly impact initial protective efficacy.
• Concomitant administration with DKTP vaccine improves long-term immunity, supporting integration into standard infant immunization programs.